Laryngeal leishmaniasis in a patient taking inhaled corticosteroids
Affiliation
Queen Elizabeth Hospital Birmingham; South Warwickshire University NHS Foundation TrustPublication date
2016-06-21Subject
Respiratory medicine
Metadata
Show full item recordAbstract
We present a case of a man in his late 60s, who had spent 3-4 months of the year in rural Spain, presenting with intermittent hoarseness of voice. He had a background of asthma and bronchiectasis, and was taking inhaled corticosteroids. His dysphonia was initially managed as bronchiectasis with little improvement. Bronchoscopy revealed a cystic lesion on his left vocal fold, and tissue biopsy revealed Leishmania amastigotes. This confirmed a diagnosis of laryngeal leishmaniasis. We propose that this is likely secondary to his inhaled corticosteroid therapy. The infection was treated with a 30-day course of miltefosine, and at most recent follow-up the patient was deemed free from leishmanial infection.Citation
Roberts RM, Mukherjee J, Phillips D. Laryngeal leishmaniasis in a patient taking inhaled corticosteroids. BMJ Case Rep. 2016 Jun 21;2016:bcr2016215444. doi: 10.1136/bcr-2016-215444.Type
ArticleAdditional Links
https://pmc.ncbi.nlm.nih.gov/articles/PMC4932416/PMID
27329097Journal
BMJ Case ReportsPublisher
BMJ Publishing Groupae974a485f413a2113503eed53cd6c53
10.1136/bcr-2016-215444